leisure time -WSS

leisure time

author：knowledge 2025-10-01 18:03:39 - browse：9471

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Congress: Prevent baby formula shortages by passing a new bill

entertainment

WSS

Congress: Prevent baby formula shortages by passing a new bill

Congress: Prevent baby formula shortages by passing a new bill

Protect nursing home residents from future pandemics

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Louisiana bill approved classifying abortion pills as controlled substances

The Bio Revolution is changing business and society

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Achieving telehealth equity for people with hearing loss

State Dept. review finds Biden bears some blame for Afghanistan failures

U.S. death rates show how politics are affecting public health

Cancer drug shortages should be causing more outrage

Bird flu makes raw milk dangerous to consume, mouse study finds

Medical records are filled with copy

Stroke rates rising, especially in working

Medical leaders decry Supreme Court decision on affirmative action

Ozempic cut risk of death in diabetes patients with chronic kidney disease

focus

Lawsuit challenges CMS nursing home minimum staffing rule

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Decentralized clinical trials need collaboration to achieve wider use

Clinicians often fail to acknowledge the pain caused by long Covid

The Bio Revolution is changing business and society

Hospitals need to get ahead of regulations on climate change

focus

entertainment

Wikipedia

leisure time